Olema Pharmaceuticals, Inc. (OLMA) Financials

OLMA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 276.9 million 23.1 million
2023-09-30 292.8 million 17.7 million
2023-06-30 177.6 million 16.0 million
2023-03-31 195.8 million 20.8 million

OLMA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -18.5 million 4.4 million
2023-09-30 -22.7 million 4.1 million
2023-06-30 -22.1 million 4.2 million
2023-03-31 -20.4 million 4.6 million

OLMA Net Income

No data available :(

OLMA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 261.8 million - 2.4 million
2023-09-30 276.9 million - 2.6 million
2023-06-30 167.4 million - 2.0 million
2023-03-31 186.0 million - 2.3 million

OLMA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 54.8 million
2023-09-30 45.0 million
2023-06-30 40.7 million
2023-03-31 40.4 million

OLMA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 25.9 million 4.5 million 88000
2023-09-30 - 19.5 million 3.9 million -
2023-06-30 - 18.0 million 3.6 million -
2023-03-31 - 22.8 million 6.8 million -

OLMA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 88000
2023-09-30 - 90000
2023-06-30 - 425000
2023-03-31 - 427000

OLMA

Price: $11.24

52 week price:
5.02
17.79

Earnings Per Share: -2.14 USD

P/E Ratio: -6.75

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 106400

Market Capitalization: 596.8 million

Links: